Steward Partners Investment Advisory, LLC Biomarin Pharmaceutical Inc Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,801 shares of BMRN stock, worth $185,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,801

Previous 2,701 3.7%

Holding current value

$185,902

Previous $235,000 2.13%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$74.43 - $92.22 $7,443 - $9,222	100 Added 3.7%	2,801 $230,000
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $4,878 - $6,304	-64 Reduced 2.31%	2,701 $260,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $1,190 - $1,322	-14 Reduced 0.5%	2,765 $244,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $22,883 - $26,479	264 Added 10.5%	2,779 $240,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $5,615 - $7,505	64 Added 2.61%	2,515 $244,000
Q1 2022 May 02, 2022	BUY	$74.28 - $92.69 $139,275 - $173,793	1,875 Added 325.52%	2,451 $189,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $747 - $854	10 Added 1.77%	576 $45,000
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $20,387 - $22,893	-270 Reduced 32.3%	566 $47,000
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $30,714 - $37,273	411 Added 96.71%	836 $63,000
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $20,185 - $25,075	278 Added 189.12%	425 $37,000
Q3 2020 Oct 30, 2020	BUY	$71.87 - $131.03 $6,827 - $12,447	95 Added 182.69%	147 $11,000
Q1 2020 Apr 29, 2020	SELL	$71.37 - $96.85 $2,069 - $2,808	-29 Reduced 35.8%	52 $4,000
Q3 2019 Oct 30, 2019	BUY	$67.4 - $85.11 $3,639 - $4,595	54 Added 200.0%	81 $5,000
Q2 2019 Jul 25, 2019	BUY	$80.35 - $93.9 $2,169 - $2,535	27 New	27 $2,000
Q4 2018 Jan 15, 2019	SELL	$80.14 - $106.07 $12,021 - $15,910	-150 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$93.92 - $105.72 $2,817 - $3,171	-30 Reduced 16.67%	150 $15,000
Q2 2018 Jul 20, 2018	SELL	$76.01 - $99.03 $3,496 - $4,555	-46 Reduced 20.35%	180 $17,000
Q1 2018 Apr 20, 2018	BUY	$77.67 - $92.63 $2,330 - $2,778	30 Added 15.31%	226 $18,000
Q3 2017 Nov 22, 2017	SELL	$80.6 - $94.95 $7,576 - $8,925	-94 Reduced 32.41%	196 $18,000
Q2 2017 Nov 22, 2017	BUY	N/A	255 Added 728.57%	290 $26,000
Q4 2016 Nov 22, 2017	BUY	N/A	35	35 $2,000

Others Institutions Holding BMRN

# of Institutions

620

Shares Held

183M

Call Options Held

1.41M

Put Options Held

1.31M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Biomarin Pharmaceutical Inc Transaction History